T. Rowe Price Investment Management Portfolio holdings
T. Rowe Price Investment Management, Inc. (TRPIM), a division of T. Rowe Price Group established in August 2022 and headquartered in Baltimore, Maryland, is an active investment manager overseeing hundreds of billions in assets, focusing on equity and fixed-income strategies for institutional clients and sub-advisory mandates. Spun off from the parent company founded in 1937 by Thomas Rowe Price, Jr., TRPIM operates as a distinct entity with around 900 employees, emphasizing a research-driven, long-term approach rooted in fundamental analysis and disciplined risk management. Managing portfolios like large-cap growth and international equity funds, it complements T. Rowe Price’s broader offerings while targeting sophisticated investors such as pension funds and endowments with tailored, high-conviction solutions. Under the leadership of president Rob Sharps, TRPIM upholds the firm’s legacy of integrity and client focus, adapting its founder’s value-oriented philosophy to modern institutional needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.66B |
| 2 |
PPL
PPL Corp
PPL
|
+$1.29B |
| 3 |
Abbott
ABT
|
+$1.23B |
| 4 |
NVIDIA
NVDA
|
+$1.02B |
| 5 |
Broadcom
AVGO
|
+$974M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Roper Technologies
ROP
|
+$1.21B |
| 2 |
Amphenol
APH
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$1.03B |
| 4 |
Autodesk
ADSK
|
+$1.02B |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
+$858M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.78% |
| 2 | Healthcare | 19.29% |
| 3 | Consumer Discretionary | 14.43% |
| 4 | Financials | 10.54% |
| 5 | Industrials | 9.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Nike
NKE
$61.2B
| $16.1M | 0.01% |
230,580
+100,545
| +77% | +$7.49M |
|
527
Humana
HUM
$46.2B
| $16M | 0.01% |
61,430
+48,762
| +385% | +$12.8M |
|
528
BellRing Brands
BRBR
$1.28B
| $15.9M | 0.01% |
438,644
-678,821
| -61% | -$30.7M |
|
529
Ametek
AME
$58.7B
| $15.9M | 0.01% |
+84,597
| New | +$15.6M |
|
530
United Parks & Resorts
PRKS
$2.04B
| $15.8M | 0.01% |
305,595
-201,898
| -40% | -$10.2M |
|
531
Pool Corp
POOL
$7.29B
| $15.8M | 0.01% |
50,917
-7,974
| -14% | -$2.5M |
|
532
Under Armour
UAA
$2.3B
| $15.7M | 0.01% |
3,153,495
-848,616
| -21% | -$4.94M |
|
533
10x Genomics
TXG
$7.58B
| $15.7M | 0.01% |
1,342,423
+364,738
| +37% | +$4.76M |
|
534
Marriott International
MAR
$91.9B
| $15.4M | 0.01% |
59,297
+18,229
| +44% | +$4.89M |
|
535
Custom Truck One Source
CTOS
$2.33B
| $14.9M | 0.01% |
2,316,067
-5,485,952
| -70% | -$31.8M |
|
536
CME Group
CME
$96.1B
| $14.8M | 0.01% |
54,959
-474,180
| -90% | -$129M |
|
537
iShares 0-3 Month Treasury Bond ETF
SGOV
$101B
| $14.7M | 0.01% |
146,402
-372,906
| -72% | -$37.5M |
|
538
Packaging Corp of America
PKG
$22.9B
| $14.7M | 0.01% |
+67,236
| New | +$13.9M |
|
539
Hanover Insurance
THG
$7.77B
| $14.1M | 0.01% |
77,842
-123,925
| -61% | -$21.2M |
|
540
Intercontinental Exchange
ICE
$87.2B
| $14.1M | 0.01% |
83,473
-558,474
| -87% | -$99.8M |
|
541
Neogen
NEOG
$2.59B
| $13.4M | 0.01% |
2,343,198
-9,925
| -0.4% | -$53K |
|
|
MRC
542
DELISTED
MRC Global
MRC
| $12.9M | 0.01% |
897,476
+379,776
| +73% | +$5.41M |
|
|
APLT
543
DELISTED
Applied Therapeutics
APLT
| $12.8M | 0.01% |
21,403,300
+2,719,310
| +15% | +$1.28M |
|
544
Westamerica Bancorp
WABC
$1.39B
| $12.3M | 0.01% |
246,529
-3,277
| -1% | -$162K |
|
545
BRC Inc
BRCC
$212M
| $12.2M | 0.01% |
+7,844,584
| New | +$12.6M |
|
546
NovoCure
NVCR
$2.02B
| $12.2M | 0.01% |
945,426
+227,371
| +32% | +$3.04M |
|
|
ASIC
547
Ategrity Specialty Insurance
ASIC
$1.2B
| $11.8M | 0.01% |
599,082
-918
| -0.2% | -$19.2K |
|
548
Utz Brands
UTZ
$1.25B
| $11.5M | 0.01% |
945,783
-474,773
| -33% | -$6.29M |
|
549
PNC Financial Services
PNC
$102B
| $11.3M | 0.01% |
56,477
-34,466
| -38% | -$6.82M |
|
550
Core Laboratories
CLB
$569M
| $11.2M | 0.01% |
908,158
+33,117
| +4% | +$388K |
|
Similar funds
T. Rowe Price Investment Management's Q3 2025 Portfolio in Review
As of Q3 2025, T. Rowe Price Investment Management held 939 positions worth $164B, up 3.3% from $158B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
T. Rowe Price Investment Management's Q3 2025 filing shows 254 new, 274 increased, 349 reduced and 60 closed positions. Its largest new stake was PPL Corp: 35,967,694 shares worth $1.34B. The largest sale was Roper Technologies, an estimated $1.21B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Investment Management's largest Q3 2025 buy was PPL Corp: 35,967,694 shares worth $1.34B.
- T. Rowe Price Investment Management added most to Apple in Q3 2025, an estimated $2.66B increase.
- T. Rowe Price Investment Management's biggest Q3 2025 reduction was Roper Technologies, cutting an estimated $1.21B.
- T. Rowe Price Investment Management fully exited RTX Corp in Q3 2025, selling an estimated $634M.
- T. Rowe Price Investment Management's ten largest holdings make up 23% of its $164B portfolio in Q3 2025.
- T. Rowe Price Investment Management opened 254 new positions and closed 60 in Q3 2025.
- T. Rowe Price Investment Management's portfolio value rose 3.3% quarter-over-quarter to $164B.
Based on T. Rowe Price Investment Management's 13F filing for Q3 2025, filed 14 Nov 2025.